Penumbra (PEN) Total Liabilities (2014 - 2026)
Penumbra's (PEN) quarterly Total Liabilities came in at $424.6 million in Q1 2026, up 11.62% year-on-year from $380.4 million in Q1 2025, and up 6.44% on a QoQ basis from $398.9 million in Q4 2025.
Penumbra (PEN) Total Liabilities (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Total Liabilities data on file, last reported at $424.6 million in Q1 2026.
- On a quarterly basis, Total Liabilities rose 11.62% year-over-year to $424.6 million in Q1 2026; TTM through Mar 2026 was $424.6 million, a 11.62% increase from a year earlier, with the FY2025 full-year figure at $398.9 million, up 4.36% from the prior year.
- Total Liabilities for Q1 2026 stood at $424.6 million, up from $398.9 million in the prior quarter.
- Over the last five years, Total Liabilities for PEN reached as high as $424.6 million in Q1 2026 and fell as low as $342.3 million in Q1 2022.
- Historically, Total Liabilities has averaged $375.0 million across 5 years, with a median of $374.8 million in 2024.
- Across the five-year window, Total Liabilities soared 79.81% in 2022 and climbed 1.09% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $372.0 million in 2022, then rose by 1.43% to $377.4 million in 2023, then advanced by 1.3% to $382.2 million in 2024, then climbed by 4.36% to $398.9 million in 2025, then climbed by 6.44% to $424.6 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $424.6 million in Q1 2026, $398.9 million in Q4 2025, and $385.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 424.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 424.63 Mn |
| Dec 31, 2025 | 398.92 Mn |
| Sep 30, 2025 | 385.67 Mn |
| Jun 30, 2025 | 380.86 Mn |
| Mar 31, 2025 | 380.43 Mn |
| Dec 31, 2024 | 382.25 Mn |
| Sep 30, 2024 | 374.84 Mn |
| Jun 30, 2024 | 373.33 Mn |
| Mar 31, 2024 | 376.31 Mn |
| Dec 31, 2023 | 377.36 Mn |
| Sep 30, 2023 | 364.24 Mn |
| Jun 30, 2023 | 365.99 Mn |
| Mar 31, 2023 | 370.83 Mn |
| Dec 31, 2022 | 372.03 Mn |
| Sep 30, 2022 | 347.85 Mn |
| Jun 30, 2022 | 357.89 Mn |
| Mar 31, 2022 | 342.27 Mn |
| Dec 31, 2021 | 290.32 Mn |
| Sep 30, 2021 | 288.64 Mn |
| Mar 31, 2021 | 190.35 Mn |